Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Regulation

Gottlieb’s exit interview

FDA Commissioner Scott Gottlieb’s exit interview

March 9, 2019 1:35 AM UTC

FDA Commissioner Scott Gottlieb sat down with BioCentury after announcing his resignation to discuss his approach to promoting medical product innovation, the importance of strategic communications, and how a reorganization will bring FDA drug reviews from PDFs to the cloud.

Gottlieb’s comments illuminate how he has shaped public debate over controversial topics, and the ways he has tried to bake new thinking into FDA so it remains after he’s moved on. He also touched on policy challenges he hopes Congress will take up soon...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article